In a three-arm RCT comparing low-dose CBD oil, placebo oil, and no treatment, placebo effects accounted for a significant portion of the improvements attributed to CBD.
CBD consumers, healthcare providers advising on CBD use, and researchers studying cannabinoid therapeutics and placebo effects.
What the researchers found
Both CBD and placebo oil groups showed improvements over the no-treatment control, suggesting that expectation and the ritual of taking a substance contribute significantly to perceived CBD benefits for stress.
Why it matters
CBD products are widely marketed for stress relief, but this study suggests the act of taking something — rather than CBD itself — may drive much of the benefit. This has major implications for consumer expectations and regulatory claims.
The numbers in context
30-day trial with three groups: CBD oil (10% full-spectrum), placebo oil, and no-treatment control. Registered as DRKS00030971.
How the study worked
Three-arm randomized controlled trial comparing 30 days of daily sublingual low-dose (10%) full-spectrum CBD oil vs. placebo oil vs. no-treatment control in stressed university students.
What this study cannot tell us
Low dose may have been insufficient for pharmacological effect. Student sample limits generalizability. 30-day duration may not capture longer-term effects.
How to read the evidence
Well-designed RCT with both placebo and no-treatment controls — strong methodology, though limited by low dose and specific population.
When this study was published
Recent RCT addressing a critical gap in CBD research by including a no-treatment control alongside placebo.
The bigger picture
The CBD market is worth billions, largely built on reported benefits that may be substantially driven by placebo effects. Rigorous trials like this help separate pharmacological reality from expectation-driven outcomes.
Questions still open
- Would higher CBD doses show clearer separation from placebo? How much of the commercial CBD market's perceived value is driven by placebo and expectation effects?
Common questions
Does this mean CBD doesn't work for stress?
Why is a no-treatment group important?
Read the original research
Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.
Journal of cannabis research, 7(1), 98
Citation
Winkler, Alexander; Meis, Annelie C; Hermann, Christiane. (2025). Placebo effects in a RCT assessing 30 days of low dose Cannabidiol (CBD) treatment for psychological distress in stressed students at risk for depression.. Journal of cannabis research, 7(1), 98. https://doi.org/10.1186/s42238-025-00366-9
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk